DI MINNO, G.; RAVASIO, R. Cost-effectiveness analysis of caplacizumab in the new standard of care for immune Thrombotic Thrombocytopenic Purpura in Italy. Global and Regional Health Technology Assessment, [S. l.], v. 8, n. 1, p. 43–52, 2021. DOI: 10.33393/grhta.2021.2191. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2191. Acesso em: 25 apr. 2024.